Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biochim Biophys Acta ; 1770(6): 890-901, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17363172

RESUMO

GPR26 and GPR78 are orphan GPCRs (oGPCRs) that share 51% amino acid sequence identity and are widely expressed in selected tissues of the human brain as well as the developing and adult mouse brain. Investigation of the functional activity of GPR26 and GPR78 via expression in HEK293 cells showed that both proteins are constitutively active and coupled to elevated cAMP production. Accordingly, in yeast, GPR26 demonstrated apparent agonist-independent coupling to a chimeric Gpa1 protein in which the 5 C-terminal amino acids were from Galphas. A comparison of the proteins revealed an atypical glutamine residue in GPR78 in place of the conserved arginine residue (R3.50) in the so-called DRY box. Site-directed mutants R3.50 in GPR26 were constructed and retained their constitutive activity suggesting that these 2 receptors activate G proteins in a manner that is distinct from other group 1 GPCRs.


Assuntos
Encéfalo/metabolismo , Receptores Acoplados a Proteínas G/biossíntese , Animais , Sequência de Bases , Encéfalo/citologia , Linhagem Celular , AMP Cíclico/biossíntese , Chaperona BiP do Retículo Endoplasmático , Subunidades alfa de Proteínas de Ligação ao GTP/biossíntese , Subunidades alfa de Proteínas de Ligação ao GTP/genética , Subunidades alfa Gq-G11 de Proteínas de Ligação ao GTP , Humanos , Masculino , Camundongos , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Mutação de Sentido Incorreto , Receptores Acoplados a Proteínas G/genética , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/genética , Proteínas de Saccharomyces cerevisiae/biossíntese , Proteínas de Saccharomyces cerevisiae/genética , Homologia de Sequência de Aminoácidos
2.
J Pharmacol Toxicol Methods ; 55(3): 303-13, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-16990017

RESUMO

INTRODUCTION: Nitric oxide (NO) has been implicated in a wide range of physiological and pathological processes. Low concentrations of this mediator play homeostatic roles, whereas many acute and chronic responses are associated with excessive production of NO. This upregulation is due in part to the induction of inducible nitric oxide synthase (iNOS) by proinflammatory cytokines in several different cell types, including macrophages and their CNS derivative, microglia. METHODS: The crystal structures of the oxygenase domains of mouse and human iNOS were superimposed using the "align by homology" feature in Sybyl (SYBYL 7.0, Tripos Inc.). NOS isoform expression was assessed by TaqMan, Western blotting, and activity assays. RESULTS: We demonstrate that there is a high degree of three-dimensional overlap between the mouse and human iNOS active centers and propose that the murine isoform can serve as a suitable substitute for the human in assays. We also demonstrate that LPS stimulation of the mouse macrophage cell line RAW 264.7 induces the expression of iNOS, but not nNOS or eNOS, at the levels of mRNA transcription and protein expression. Furthermore, the pharmacology and calcium dependency of the NO formation support the finding that it is due to iNOS alone. Also reported is the demonstration of LPS-induced RAW 264.7 macrophages in simple cell-based and cell-free screening assays for iNOS inhibitors. Both assays were reproducible, as demonstrated by Z' factors of 0.69 and 0.71, and had high signal to noise ratios of 11- and 6-fold for the cell-based and cell-free assay, respectively. DISCUSSION: Our computational analyses indicate that there is a high degree of three-dimensional overlap between the oxygenase domains of human and murine iNOS. This observation together with the selective induction of murine iNOS in RAW 264.7 macrophages demonstrates the potential utility of the mouse iNOS assay to identify inhibitors of the human enzyme.


Assuntos
Regulação da Expressão Gênica , Lipopolissacarídeos/farmacologia , Óxido Nítrico Sintase Tipo II/metabolismo , Óxido Nítrico/metabolismo , Homologia Estrutural de Proteína , Animais , Western Blotting , Cálcio , Linhagem Celular , Simulação por Computador , Citocinas , Humanos , Macrófagos/metabolismo , Camundongos , Microglia/metabolismo , Óxido Nítrico/biossíntese , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores , Isoformas de Proteínas , RNA Mensageiro , Reprodutibilidade dos Testes , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Alinhamento de Sequência , Especificidade da Espécie , Transcrição Gênica
3.
Bioinformatics ; 20(18): 3490-9, 2004 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-15297294

RESUMO

MOTIVATION: Determining the coupling specificity of G-protein coupled receptors (GPCRs) is important for understanding the biology of this class of pharmacologically important proteins. Currently available in silico methods for predicting GPCR-G-protein coupling specificity have high error rate. METHOD: We introduce a new approach for creating hidden Markov models (HMMs) based on a first guess about the importance of various residues. We call these knowledge restricted HMMs to emphasize the fact that the state space of the HMM is restricted by the application of a priori knowledge. Specifically, we use only those amino acid residues of GPCRs which are likely to interact with G-proteins, namely those that are predicted to be in the intra-cellular loops. Furthermore, we concatenate these predicted loops into one sequence rather than considering them as four disparate units. This reduces the HMM state space by drastically decreasing the sequence length. RESULTS: Our knowledge restricted HMM based method to predict GPCR-G-protein coupling specificity has an error rate of <1%, when applied to a test set of GPCRs with known G-protein coupling specificity. AVAILABILITY: Academic users can get the data set mentioned herein and HMMs from the authors.


Assuntos
Proteínas de Ligação ao GTP/química , Modelos Químicos , Mapeamento de Interação de Proteínas/métodos , Receptores Acoplados a Proteínas G/química , Alinhamento de Sequência/métodos , Análise de Sequência de Proteína/métodos , Sítios de Ligação , Simulação por Computador , Cadeias de Markov , Modelos Estatísticos , Ligação Proteica , Homologia de Sequência de Aminoácidos , Relação Estrutura-Atividade
4.
J Virol ; 78(6): 2921-34, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14990710

RESUMO

The purified T-antigen origin binding domain binds site specifically to site II, the central region of the simian virus 40 core origin. However, in the context of full-length T antigen, the origin binding domain interacts poorly with DNA molecules containing just site II. Here we investigate the contributions of additional core origin regions, termed the flanking sequences, to origin recognition and the assembly of T-antigen hexamers and double hexamers. Results from these studies indicate that in addition to site-specific binding of the T-antigen origin binding domain to site II, T-antigen assembly requires non-sequence-specific interactions between a basic finger in the helicase domain and particular flanking sequences. Related studies demonstrate that the assembly of individual hexamers is coupled to the distortions in the proximal flanking sequence. In addition, the point in the double-hexamer assembly process that is regulated by phosphorylation of threonine 124, the sole posttranslational modification required for initiation of DNA replication, was further analyzed. Finally, T-antigen structural information is used to model various stages of T-antigen assembly on the core origin and the regulation of this process.


Assuntos
Antígenos Virais de Tumores/metabolismo , Modelos Moleculares , Origem de Replicação/fisiologia , Vírus 40 dos Símios/metabolismo , Montagem de Vírus , Animais , Antígenos Virais de Tumores/química , Sequência de Bases , Células Cultivadas , Replicação do DNA , Dados de Sequência Molecular , Spodoptera , Replicação Viral
5.
Arch Biochem Biophys ; 420(1): 55-67, 2003 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-14622975

RESUMO

The NARC 1 gene encodes a novel proteinase K family proteinase. The domain structure of rat Narc 1 resembles that of the subtilisin-like proprotein convertases (SPCs), except that rNarc 1 lacks the canonical P-domain of SPCs, retaining only the RGD motif as part of what might be a cryptically functioning P-domain. Narc 1 undergoes autocatalytic intramolecular processing at the site LVFAQ/, resulting in the cleavage of its prosegment and the generation of an active proteinase with a broad alkaline pH optimum and no apparent calcium requirement for activity. Both primary and secondary structural determinants influence Narc 1 substrate recognition. Our functional characterization of Narc 1 reinforces the inference drawn from the analysis of its predicted structure that this enzyme is most closely related to representatives of the proteinase K family, but that it is also sufficiently different to warrant its possible classification in a separate sub-family.


Assuntos
Endopeptidase K/química , Endopeptidase K/metabolismo , Modelos Químicos , Alinhamento de Sequência , Análise de Sequência de Proteína , Serina Endopeptidases/química , Serina Endopeptidases/metabolismo , Motivos de Aminoácidos , Sequência de Aminoácidos , Animais , Cálcio/química , Ativação Enzimática , Estabilidade Enzimática , Regulação Enzimológica da Expressão Gênica/fisiologia , Concentração de Íons de Hidrogênio , Dados de Sequência Molecular , Oligopeptídeos/química , Pró-Proteína Convertase 9 , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Ratos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Homologia de Sequência , Relação Estrutura-Atividade , Temperatura
6.
FEBS Lett ; 524(1-3): 163-71, 2002 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-12135761

RESUMO

The p53 tumor suppressor protein induces cell cycle arrest or apoptosis in response to cellular stresses. We have identified PRG3 (p53-responsive gene 3), which is induced specifically under p53-dependent apoptotic conditions in human colon cancer cells, and encodes a novel polypeptide of 373 amino acids with a predicted molecular mass of 40.5 kDa. PRG3 has significant homology to bacterial oxidoreductases and the apoptosis-inducing factor, AIF, and the gene was assigned to chromosome 10q21.3-q22.1. Expression of PRG3 was induced by the activation of endogenous p53 and it contains a p53-responsive element. Unlike AIF, PRG3 localizes in the cytoplasm and its ectopic expression induces apoptosis. An amino-terminal deletion mutant of PRG3 that lacks a putative oxidoreductase activity retains its apoptotic activity, suggesting that the oxidoreductase activity is dispensable for the apoptotic function of PRG3. The PRG3 gene is thus a novel p53 target gene in a p53-dependent apoptosis pathway.


Assuntos
Flavoproteínas/genética , Regulação da Expressão Gênica/fisiologia , Proteínas de Membrana/genética , Proteínas Mitocondriais , Proteínas/genética , Proteína Supressora de Tumor p53/fisiologia , Difosfato de Adenosina/metabolismo , Motivos de Aminoácidos , Sequência de Aminoácidos , Fator de Indução de Apoptose , Proteínas Reguladoras de Apoptose , Sequência de Bases , Sítios de Ligação , Mapeamento Cromossômico , Cromossomos Humanos Par 10 , Clonagem Molecular , DNA , Genes Reporter , Humanos , Hibridização in Situ Fluorescente , Dados de Sequência Molecular , Proteínas/química , RNA Mensageiro/genética , Homologia de Sequência de Aminoácidos , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA